Bio Protocol vs Covalent X Token — how do they compare? Bio Protocol trades at Rp438.7 (market cap Rp990,24M, Rp174,03M 24h volume), while Covalent X Token trades at Rp42.98 (market cap Rp41,66M, Rp2,61M 24h volume). The key difference: Bio Protocol is far larger — about 23.8× Covalent X Token's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 969,3M / 1B CXT (97%) for Covalent X Token. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Covalent X Token for 5 Days on average.
| BIO | CXT | |
|---|---|---|
Market Cap | Rp990,24M | Rp41,66M |
Volume (24h) | Rp174,03M | Rp2,61M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 969,3M / 1B CXT (97%) |
Typical Hold Time | 18 Days | 5 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
CXT is trading at Rp43.04 with a market cap of Rp41.71M, showing 97% circulating supply distribution. The token demonstrates moderate network activity with a 4-day average hold time. Recent trading patterns indicate stable price action within a narrow range, suggesting consolidation phase. No major protocol upgrades or ecosystem developments have been reported recently, maintaining baseline network functionality.
Outlook remains neutral with limited near-term catalysts. Key opportunity lies in potential ecosystem expansion, while risks include low liquidity and typical crypto volatility. Investors should monitor for protocol updates and exchange listing developments that could impact token utility and valuation.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →CXT is the utility and governance token of the Covalent Network, which safeguards Ethereum’s historical data. It is used for staking and enables holders to participate in decentralized governance. The network enhances data availability for developers building on the Ethereum ecosystem.
Read more on CXT →